S. Aufa and J. Ismy, “Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer”, IJGHR, vol. 8, no. 6, pp. 89–98, Sep. 2026.